Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
140 tokens/sec
GPT-4o
7 tokens/sec
Gemini 2.5 Pro Pro
46 tokens/sec
o3 Pro
4 tokens/sec
GPT-4.1 Pro
38 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

Weighting methods for truncation by death in cluster-randomized trials (2404.10629v1)

Published 16 Apr 2024 in stat.ME and stat.AP

Abstract: Patient-centered outcomes, such as quality of life and length of hospital stay, are the focus in a wide array of clinical studies. However, participants in randomized trials for elderly or critically and severely ill patient populations may have truncated or undefined non-mortality outcomes if they do not survive through the measurement time point. To address truncation by death, the survivor average causal effect (SACE) has been proposed as a causally interpretable subgroup treatment effect defined under the principal stratification framework. However, the majority of methods for estimating SACE have been developed in the context of individually-randomized trials. Only limited discussions have been centered around cluster-randomized trials (CRTs), where methods typically involve strong distributional assumptions for outcome modeling. In this paper, we propose two weighting methods to estimate SACE in CRTs that obviate the need for potentially complicated outcome distribution modeling. We establish the requisite assumptions that address latent clustering effects to enable point identification of SACE, and we provide computationally-efficient asymptotic variance estimators for each weighting estimator. In simulations, we evaluate our weighting estimators, demonstrating their finite-sample operating characteristics and robustness to certain departures from the identification assumptions. We illustrate our methods using data from a CRT to assess the impact of a sedation protocol on mechanical ventilation among children with acute respiratory failure.

Definition Search Book Streamline Icon: https://streamlinehq.com
References (70)
  1. Design and analysis of group-randomized trials: a review of recent methodological developments. American journal of public health, 94(3):423–432, 2004.
  2. Review of recent methodological developments in group-randomized trials: part 1—design. American journal of public health, 107(6):907–915, 2017a.
  3. Cluster randomised trials. CRC press, 2017.
  4. Paul R Rosenbaum. The consequences of adjustment for a concomitant variable that has been affected by the treatment. Journal of the Royal Statistical Society Series A: Statistics in Society, 147(5):656–666, 1984.
  5. Inference in randomized trials with death and missingness. Biometrics, 73(2):431–440, 2017.
  6. How conditioning on posttreatment variables can ruin your experiment and what to do about it. American Journal of Political Science, 62(3):760–775, 2018.
  7. Principal stratification in causal inference. Biometrics, 58(1):21–29, 2002.
  8. Donald B Rubin. More powerful randomization-based p-values in double-blind trials with non-compliance. Statistics in medicine, 17(3):371–385, 1998.
  9. Likelihood-based analysis of causal effects of job-training programs using principal stratification. Journal of the American Statistical Association, 104(485):166–176, 2009.
  10. Improving inference of gaussian mixtures using auxiliary variables. Statistical Analysis and Data Mining: The ASA Data Science Journal, 8(1):34–48, 2015.
  11. An estimator for treatment comparisons among survivors in randomized trials. Biometrics, 61(1):305–310, 2005.
  12. Principal stratification analysis using principal scores. Journal of the Royal Statistical Society. Series B (Statistical Methodology), pages 757–777, 2017.
  13. Matching methods for truncation by death problems. Journal of the Royal Statistical Society Series A: Statistics in Society, 186(4):659–681, 2023.
  14. Review of recent methodological developments in group-randomized trials: part 2—analysis. American journal of public health, 107(7):1078–1086, 2017b.
  15. Propensity score weighting with multilevel data. Statistics in medicine, 32(19):3373–3387, 2013.
  16. A bayesian approach for estimating the survivor average causal effect when outcomes are truncated by death in cluster-randomized trials. American Journal of Epidemiology, 192(6):1006–1015, 2023.
  17. Bayesian framework for causal inference with principal stratification and clusters. Statistics in Biosciences, 15(1):114–140, 2023.
  18. A mixed model approach to estimate the survivor average causal effect in cluster-randomized trials. Statistics in Medicine, 2023.
  19. The calculus of m-estimation. The American Statistician, 56(1):29–38, 2002.
  20. Longitudinal data analysis using generalized linear models. Biometrika, 73(1):13–22, 1986.
  21. Dane Isenberg. PtSaceCrts: Estimation of SACE. R package version 0.0.0.9000, 2024. https://github.com/abcdane1/PtSaceCrts.
  22. Estimation of causal effects via principal stratification when some outcomes are truncated by “death”. Journal of Educational and Behavioral Statistics, 28(4):353–368, 2003.
  23. Estimands in cluster-randomized trials: choosing analyses that answer the right question. International Journal of Epidemiology, 52(1):107–118, 2023.
  24. Single world intervention graphs (swigs): A unification of the counterfactual and graphical approaches to causality. Center for the Statistics and the Social Sciences, University of Washington Series. Working Paper, 128(30):2013, 2013.
  25. Stephen W Raudenbush. Statistical analysis and optimal design for cluster randomized trials. Psychological methods, 2(2):173, 1997.
  26. Marginalized multilevel models and likelihood inference (with comments and a rejoinder by the authors). Statistical Science, 15(1):1–26, 2000.
  27. Methods to reduce the impact of intraclass correlation in group-randomized trials. Evaluation Review, 27(1):79–103, 2003.
  28. Determinants of the intracluster correlation coefficient in cluster randomized trials: the case of implementation research. Clinical Trials, 2(2):99–107, 2005.
  29. Bootstrapping clustered data. Journal of the Royal Statistical Society Series B: Statistical Methodology, 69(3):369–390, 2007.
  30. Multiply robust generalized estimating equations for cluster randomized trials with missing outcomes. Statistics in Medicine, 2024.
  31. HK Iverson and RH Randles. The effects on convergence of substituting parameter estimates into u-statistics and other families of statistics. Probability Theory and Related Fields, 81(3):453–471, 1989.
  32. Model-based inference on average causal effect in observational clustered data. Health Services and Outcomes Research Methodology, 19:36–60, 2019.
  33. A note on gauss—hermite quadrature. Biometrika, 81(3):624–629, 1994.
  34. A comparison of cluster-specific and population-averaged approaches for analyzing correlated binary data. International Statistical Review/Revue Internationale de Statistique, pages 25–35, 1991.
  35. Conditional and marginal models: Another view. Statistical Science, 19(2):219–238, 2004.
  36. Marginal or conditional regression models for correlated non-normal data? Methods in Ecology and Evolution, 7(12):1514–1524, 2016.
  37. A practitioner’s guide to cluster-robust inference. Journal of human resources, 50(2):317–372, 2015.
  38. Small sample performance of bias-corrected sandwich estimators for cluster-randomized trials with binary outcomes. Statistics in medicine, 34(2):281–296, 2015.
  39. Robustness issues in multilevel regression analysis. Statistica Neerlandica, 58(2):127–137, 2004.
  40. Accounting for heteroskedasticity resulting from between-group differences in multilevel models. Multivariate Behavioral Research, pages 1–21, 2022.
  41. An assessment of estimation procedures for multilevel models with binary responses. Journal of the Royal Statistical Society: Series A (Statistics in Society), 158(1):73–89, 1995.
  42. Increased risk of type i errors in cluster randomised trials with small or medium numbers of clusters: a review, reanalysis, and simulation study. Trials, 17:1–8, 2016.
  43. Some heteroskedasticity-consistent covariance matrix estimators with improved finite sample properties. Journal of econometrics, 29(3):305–325, 1985.
  44. Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under nonstandard conditions. Journal of the American Statistical Association, 82(398):605–610, 1987.
  45. Package ‘lme4’. URL http://lme4. r-forge. r-project. org, 2009.
  46. Random effects structure for confirmatory hypothesis testing: Keep it maximal. Journal of memory and language, 68(3):255–278, 2013.
  47. A nondegenerate penalized likelihood estimator for variance parameters in multilevel models. Psychometrika, 78:685–709, 2013.
  48. Using simulation studies to evaluate statistical methods. Statistics in medicine, 38(11):2074–2102, 2019.
  49. Multiply robust estimation of causal effects under principal ignorability. Journal of the Royal Statistical Society Series B: Statistical Methodology, 84(4):1423–1445, 2022.
  50. Instrumental variable estimation when compliance is not deterministic: the stochastic monotonicity assumption. arXiv preprint arXiv:1407.7308, 2014.
  51. Partitioning variation in multilevel models. Understanding statistics: statistical issues in psychology, education, and the social sciences, 1(4):223–231, 2002.
  52. The intra-cluster correlation coefficient in cluster randomized trials: a review of definitions. International Statistical Review, 77(3):378–394, 2009.
  53. Models for longitudinal data: a generalized estimating equation approach. Biometrics, pages 1049–1060, 1988.
  54. Cluster randomised trials with a binary outcome and a small number of clusters: comparison of individual and cluster level analysis method. BMC Medical Research Methodology, 22(1):1–15, 2022.
  55. Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: a randomized clinical trial. Jama, 313(4):379–389, 2015.
  56. The pediatric risk of mortality score: update 2015. Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 17(1):2, 2016.
  57. Debra Henry Fiser. Assessing the outcome of pediatric intensive care. The Journal of pediatrics, 121(1):68–74, 1992.
  58. Does cox analysis of a randomized survival study yield a causal treatment effect? Lifetime data analysis, 21:579–593, 2015.
  59. Subtleties in the interpretation of hazard contrasts. Lifetime Data Analysis, 26:833–855, 2020.
  60. A sensitivity analysis approach for the causal hazard ratio in randomized and observational studies. Biometrics, 79(3):2743–2756, 2023.
  61. On semi-competing risks data. Biometrika, 88(4):907–919, 2001.
  62. A bayesian nonparametric approach for evaluating the causal effect of treatment in randomized trials with semi-competing risks. Biostatistics, 23(1):34–49, 2022.
  63. Conditional separable effects. Journal of the American Statistical Association, pages 1–13, 2022.
  64. Inference under Covariate-Adaptive Randomization with Multiple Treatments. arXiv preprint arXiv:2204.08356, August 2023.
  65. Model-robust and efficient covariate adjustment for cluster-randomized experiments. Journal of the American Statistical Association, pages 1–13, 2024.
  66. Rationale, methodological quality, and reporting of cluster-randomized controlled trials in critical care medicine: a systematic review. Critical Care Medicine, 49(6):977–987, 2021.
  67. Catherine M Crespi. Improved designs for cluster randomized trials. Annual Review of Public Health, 37:1–16, 2016.
  68. The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. Bmj, 350, 2015.
  69. Robert J Serfling. Approximation theorems of mathematical statistics. John Wiley & Sons, 2009.
  70. Average causal effects from nonrandomized studies: a practical guide and simulated example. Psychological methods, 13(4):279, 2008.

Summary

We haven't generated a summary for this paper yet.